Susquehanna International Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-108,297
| Closed | -$200K | – | 6856 |
|
|
2023
Q1 | $200K | Buy |
108,297
+79,005
| +270% | +$146K | ﹤0.01% | 4869 |
|
|
2022
Q4 | $32.5K | Buy |
29,292
+7,025
| +32% | +$7.8K | ﹤0.01% | 5267 |
|
|
2022
Q3 | $52K | Sell |
22,267
-18,988
| -46% | -$44.3K | ﹤0.01% | 5488 |
|
|
2022
Q2 | $125K | Buy |
+41,255
| New | +$125K | ﹤0.01% | 4886 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6813 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6668 |
|
|
2021
Q3 | – | Sell |
-12,108
| Closed | -$82K | – | 6320 |
|
|
2021
Q2 | $82K | Sell |
12,108
-10,014
| -45% | -$67.8K | ﹤0.01% | 5099 |
|
|
2021
Q1 | $227K | Sell |
22,122
-3,806
| -15% | -$39.1K | ﹤0.01% | 4656 |
|
|
2020
Q4 | $181K | Buy |
25,928
+12,011
| +86% | +$83.8K | ﹤0.01% | 4311 |
|
|
2020
Q3 | $114K | Buy |
+13,917
| New | +$114K | ﹤0.01% | 4061 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5158 |
|
|
2020
Q1 | – | Sell |
-48,325
| Closed | -$422K | – | 5203 |
|
|
2019
Q4 | $422K | Buy |
48,325
+28,084
| +139% | +$245K | ﹤0.01% | 2827 |
|
|
2019
Q3 | $67K | Buy |
20,241
+3,917
| +24% | +$13K | ﹤0.01% | 4159 |
|
|
2019
Q2 | $81K | Sell |
16,324
-28,299
| -63% | -$140K | ﹤0.01% | 4200 |
|
|
2019
Q1 | $277K | Buy |
44,623
+18,915
| +74% | +$117K | ﹤0.01% | 2321 |
|
|
2018
Q4 | $87K | Sell |
25,708
-151,674
| -86% | -$513K | ﹤0.01% | 3227 |
|
|
2018
Q3 | $1.15M | Buy |
177,382
+126,570
| +249% | +$823K | ﹤0.01% | 1336 |
|
|
2018
Q2 | $389K | Sell |
50,812
-46,538
| -48% | -$356K | ﹤0.01% | 2464 |
|
|
2018
Q1 | $2.18M | Buy |
97,350
+84,531
| +659% | +$1.89M | ﹤0.01% | 911 |
|
|
2017
Q4 | $163K | Buy |
+12,819
| New | +$163K | ﹤0.01% | 3210 |
|